Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
StemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer 2021-12-13 07:00
Concord Medical Reports Financial Results for the First Half of 2021 2021-12-10 18:39
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan 2021-12-10 12:17
Trajan to acquire LEAP PAL Parts 2021-12-09 21:00
I-Mab to Hold Investor Call to Present In-depth Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma 2021-12-09 21:00
WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan 2021-12-09 08:00
Novalis LifeSciences Launches its Second Life Science Investment Fund with $300M and announces key new team members. 2021-12-09 00:00
I-Mab Announces First Patient Dosed in U.S. Phase 1 Study of Protollin for the Treatment of Alzheimer's Disease 2021-12-08 21:00
Nippon Express (Nederland) Acquires GDP Compliance Certification for Company-owned Warehouse 2021-12-08 14:00
China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again 2021-12-07 21:33
Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting 2021-12-07 21:32
I-Mab to Pursue Dual Listing Plan on The Main Board of The Stock Exchange of Hong Kong Limited 2021-12-07 21:00
SyMap Medical Ltd. Closes Largest Financing Round in Renal Denervation Field 2021-12-07 20:30
Samsung Biologics adds to global ISO certifications with Quality Management System 2021-12-07 13:04
Akeso Announces Launch of U.S. Investigator-Initiated Study of Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) 2021-12-07 08:20
IMPACT 2021 R&D Day: Synthetic Lethality Provides a New Platform for Targeted Cancer Therapy 2021-12-06 16:03
Odyssey Announces Agreement to Combine with BenevolentAI 2021-12-06 14:00
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China 2021-12-06 09:16
Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma 2021-12-04 21:00
I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors 2021-12-03 21:00
1 149 150 151 152 153 433